AVHH.L Stock Overview
Operates as a regenerative medicine company in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
AVITA Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.31 |
| 52 Week High | US$3.45 |
| 52 Week Low | US$1.41 |
| Beta | 1.54 |
| 11 Month Change | 22.64% |
| 3 Month Change | 42.59% |
| 1 Year Change | -12.17% |
| 33 Year Change | 15.50% |
| 5 Year Change | 437.21% |
| Change since IPO | 670.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVHH.L | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 2.1% | 2.5% | 2.2% |
| 1Y | -12.2% | 16.1% | 31.6% |
Return vs Industry: AVHH.L underperformed the US Biotechs industry which returned 16.1% over the past year.
Return vs Market: AVHH.L underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| AVHH.L volatility | |
|---|---|
| AVHH.L Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AVHH.L's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine AVHH.L's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 207 | Jim Corbett | www.avitamedical.com |
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time.
AVITA Medical, Inc. Fundamentals Summary
| AVHH.L fundamental statistics | |
|---|---|
| Market cap | US$349.90m |
| Earnings (TTM) | -US$57.32m |
| Revenue (TTM) | US$60.04m |
5.8x
P/S Ratio-6.1x
P/E RatioIs AVHH.L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVHH.L income statement (TTM) | |
|---|---|
| Revenue | US$60.04m |
| Cost of Revenue | US$8.61m |
| Gross Profit | US$51.43m |
| Other Expenses | US$108.75m |
| Earnings | -US$57.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.19 |
| Gross Margin | 85.66% |
| Net Profit Margin | -95.47% |
| Debt/Equity Ratio | 348.0% |
How did AVHH.L perform over the long term?
See historical performance and comparison